• Joan Rivers Being Taken Out of Coma: Details

    Doctors began to take Joan Rivers out of her coma on Sunday, Aug. 31, sources tell Us Weekly — get new details

    Us Weekly
  • Joan Rivers Being Brought Out of Coma

    A source tells ET that doctors have started the process of bringing Joan Rivers out of a medically induced coma. A source tells ET that doctors started the process of bringing Joan Rivers out of a medically induced coma yesterday. The Fashion Police judge, 81, was placed under a medically induced…

    ET Online
  • Fiorentina announce Giuseppe Rossi will undergo more knee surgery

    The 27-year-old midfielder can't catch a break, as his knee fails him yet again.

    NBC Sports
  • Why anti-drug campaigns like DARE fail

    Plenty of adults remember DARE, the anti-drug education program used by schools since it launched in 1983. As the country moves toward relaxing its drug laws through marijuana legalization and other measures, education and rehabilitation programs will become the focus for public officials who want…
  • Denmark's Novo Nordisk launches Ryzodeg in Mexico

    COPENHAGEN (Reuters) - Novo Nordisk (NOVOb.CO) has launched its type 2 diabetes treatment Ryzodeg in Mexico, a combination drug that could reap the company billions in revenues in years to come. Ryzodeg ...

  • Cyberonics device improves heart function after Boston flop

    A nerve stimulation device from Cyberonics improved cardiac function in heart failure patients in a small clinical trial, in contrast to an unsuccessful study backed by Boston Scientific. Both companies are trying to improve outcomes for patients with heart failure, in which the heart fails to pump…

  • Play

    ON VIDEO: Breakthrough for mom with Alzheimer's

    Kelly Gunderson's camera happened to be rolling when her mom, who suffers from Alzheimer's disease, surprised everyone by recognizing her.

    WPVI – Philadelphia
  • How Will Millennials Face Their Parents' Aging? With Wearable Tech And Human Touch

    In the past year my wife and I have moved my father from Missouri to Colorado, acted as amateur health assistants and social workers, found him the resources he needed to live as safely and independently as possible, all while both of us were in the middle of balancing work [...]

  • Astra heart pill safe to use in ambulance but no extra benefit

    AstraZeneca's blood-thinning drug Brilinta is safe to use in the ambulance when heart attack patients are being rushed to hospital but giving it early in this way does not provide any extra benefit. Encouragingly, early use was not associated with excess bleeding, a potential problem with blood…

  • Early Hint At Cardiovascular Outcomes With Sanofi's and Regeneron's Rapidly Advancing Cholesterol Drug

    Amid a slew of new data demonstrating yet again that PCSK9 inhibitors lower LDL cholesterol-- drastically and in a wide variety of different patient populations-- data from one trial offers the first suggestion that the drugs may in fact improve cardiovascular outcomes. But the analysis, the…

  • Children Using e-Cigarettes Are More at Risk of Trying Cigarettes

    The Centers for Disease Control and Prevention reports that e-cigarette use by teens is on the rise.

    Motley Fool
  • In America, Only The Poor's Eating Habits Aren't Improving

    CHICAGO (AP) — Americans' eating habits have improved — except among the poor, evidence of a widening wealth gap when it comes to diet. Yet even among wealthier adults, food choices remain far from ideal, a 12-year study found. On an index of healthy eating where a perfect score is 110, U.S. adults…

    Huffington Post
  • Judge blocks Louisiana abortion law

    A federal judge temporarily blocked enforcement of Louisiana's tough new abortion law shortly before it was to take effect on Monday. The law will technically remain on the books for now, but doctors can't be penalized for violating it until a court challenge is resolved.

    The Week (RSS)
  • SIGNIFY Trial Provokes Sound And Fury Over Controversial Servier and Amgen Drug

    The controversial drug ivabradine just got a little more controversial. The drug, which is marketed by Servier under the brand names of Corlentor and Procoralan, is available in Europe and elsewhere and is used for the treatment of heart failure and stable angina. The drug is not available in the…

  • I'll beat alcohol, says troubled Gascoigne

    Troubled former England star Paul Gascoigne has told a British newspaper he will overcome his problems with alcoholism after recently being hospitalised following a drinking binge. I am an alcoholic so I am taking one day at a time, but I will get there," Gascoigne told the Sunday Mirror. He…

  • Exelixis to cut jobs after prostate cancer drug fails late-stage study

    Cancer drug developer Exelixis Inc said on Monday it would cut about 70 percent of its workforce after its experimental prostate cancer drug cabozantinib failed a late-stage study. The drug did not show a statistically significant increase in overall survival in men treated with cabozantinib as…

  • Can Health Care Success Be Health Care Disaster?

    How can success be disaster, even in health care? As the Michael W. Smith song says, "Let me show you the way." Remember that health care one word means a system, one that currently accounts for 20 percent of U.S. national spending. Health care -- two words -- refers to a personal service…

    Huffington Post
  • Novartis Japan admits concealing drug side effects

    The Japanese unit of Swiss pharma giant Novartis has admitted it did not report more than 2,500 cases of serious side effects in patients using its leukaemia and other cancer drugs, reportedly including some fatalities.

  • With This Mobile Device, Your Smartphone Could Diagnose Disease in Minutes

    OK, maybe not, but this technology isn’t as far off as you think. A Philadelphia tech start-up’s newest invention, Biomeme, is a lightweight mobile system that can perform DNA diagnostics and real-time disease surveillance by leveraging the computing power of an iPhone or iPod.